Atelerix Raises Seed Round
Cell encapsulation start-up enables the shipment of human cells at room temperature, overcoming problems of…read more
Atelerix is a new company based at the Babraham Research Campus in Cambridge and spunout from the research of BBSRC researcher Che Connon at the University of Newcastle.
Atelerix is commercialising a patented simple, low cost system capable of preserving the viability and functionality of cells at hypothermic temperatures (4°C to 21°C). Used as a method of cell storage and transport, it overcomes the acknowledged problems associated with cryo- shipping. Cells are encapsulated by in situ formation of the gel for shipping in plates or vials, and can be rapidly released from the gel by the addition of a simple buffer.
Associated Fund UK Innovation & Science Seed Fund
Sector Medical / Biotechnology